STOCK TITAN

HYPERFINE Stock Price, News & Analysis

HYPR NASDAQ

Company Description

Overview of Hyperfine Inc (HYPR)

Hyperfine Inc is a pioneering medical device company transforming diagnostic imaging with its innovative Swoop portable MR imaging system. This ultra-low-field, portable MRI solution offers clinicians the ability to obtain high-quality brain images directly at the patient’s bedside, addressing challenges posed by traditional, immobile MRI systems. With a design that allows the device to plug into standard electrical outlets and be controlled via an Apple iPad, Hyperfine provides an agile imaging solution that is both cost-effective and efficient.

Core Business Areas and Technology

At the heart of Hyperfine’s operations is the mission to make magnetic resonance imaging accessible to every patient regardless of location. The company’s core business is centered on:

  • Device Sales: Offering the Swoop system as a practical alternative to fixed, conventional MRI units, which are often expensive and limited to specific facilities.
  • Service Subscriptions: Bundled offerings that include maintenance, software updates, and additional support, ensuring streamlined operations and an integrated user experience.

Utilizing ultra-low magnetic field technology, the Swoop system is designed for rapid deployment in various clinical settings such as neurointensive care, emergency departments, pediatrics, and more. This approach not only supports critical decision-making with fast turnaround imaging but also complements conventional MRI systems by extending imaging capabilities to underserved environments.

Market Position and Competitive Landscape

Hyperfine Inc has established a unique niche in the healthcare technology market. Its strategic positioning as a provider of accessible and portable MRI solutions differentiates it in an industry traditionally dominated by fixed, high-cost imaging machines. The streamlined training process—where new users can achieve operational competence within a short time frame—underscores Hyperfine’s commitment to improving clinical workflow and efficiency. Moreover, the company’s ability to deliver diagnostic imaging to multiple care sites positions it strategically in an expanding market segment concerned with patient-centric, mobile imaging solutions.

Technology and Clinical Impact

Key to Hyperfine’s success is its innovative approach to MR imaging. The Swoop system leverages portable MRI and diagnostic imaging technologies to provide rapid and actionable insights during critical patient care. By facilitating near-instant image availability, it bolsters the capacity for timely clinical interventions. The ease of integration into existing clinical settings, including its simple plug-and-play nature and intuitive interface, has allowed for a broader adaptation by medical professionals who previously faced the logistical hurdles of conventional imaging modalities.

Operational Excellence and Service Model

The company’s revenue model is built on both hardware sales and recurring service subscriptions. This dual approach not only supports the initial acquisition of the imaging system but also ensures continuous improvements and maintenance through periodic service contracts. Hyperfine’s service model is designed to enhance device longevity and performance, solidifying the system’s place as a dependable clinical asset. The emphasis on ease of use—evidenced by a brief training period—further reflects the company’s commitment to operational excellence.

Clinical Relevance and Safety

Hyperfine’s imaging system has been rigorously designed to align with clinical requirements, delivering safe and effective imaging that meets regulatory standards. By focusing on bedside accessibility and image clarity, the company addresses a critical gap in healthcare delivery, particularly in emergency and intensive care situations where time is a crucial factor. The ability to generate images quickly, while ensuring ease of use and patient safety, underscores the technological sophistication underlying the Swoop system.

Conclusion

In summary, Hyperfine Inc (HYPR) is at the forefront of a shift in the diagnostic imaging landscape. By offering a portable, efficient, and user-friendly MRI solution, the company addresses longstanding limitations in access and timely imaging. Its diversified revenue streams through device and subscription sales demonstrate a robust business model tailored to modern healthcare needs. The company’s clear focus on operational excellence, technological innovation, and clinical efficiency makes it a significant entity in the evolving field of medical diagnostics.

Stock Performance

$0.7570
0.00%
0.00
Last updated: April 27, 2025 at 15:59
-8.9 %
Performance 1 year
$54.2M
Market Cap
77.8M
Shares outstanding

SEC Filings

No SEC filings available for HYPERFINE.

Financial Highlights

$12,890,000
Revenue (TTM)
-$40,720,000
Net Income (TTM)
-$0.56
Diluted EPS (TTM)
-$38,767,000
Operating Cash Flow
-315.90%
Net Profit Margin
-335.33%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of HYPERFINE (HYPR)?

The current stock price of HYPERFINE (HYPR) is $0.757 as of April 25, 2025.

What is the market cap of HYPERFINE (HYPR)?

The market cap of HYPERFINE (HYPR) is approximately 54.2M.

What is the revenue (TTM) of HYPERFINE (HYPR) stock?

The trailing twelve months (TTM) revenue of HYPERFINE (HYPR) is $12,890,000.

What is the net income of HYPERFINE (HYPR)?

The trailing twelve months (TTM) net income of HYPERFINE (HYPR) is -$40,720,000.

What is the earnings per share (EPS) of HYPERFINE (HYPR)?

The diluted earnings per share (EPS) of HYPERFINE (HYPR) is -$0.56 on a trailing twelve months (TTM) basis.

What is the operating cash flow of HYPERFINE (HYPR)?

The operating cash flow of HYPERFINE (HYPR) is -$38,767,000.

What is the profit margin of HYPERFINE (HYPR)?

The net profit margin of HYPERFINE (HYPR) is -315.90%.

What is the operating margin of HYPERFINE (HYPR)?

The operating profit margin of HYPERFINE (HYPR) is -335.33%.

What is the gross margin of HYPERFINE (HYPR)?

The gross profit margin of HYPERFINE (HYPR) is 45.70%.

What is the current ratio of HYPERFINE (HYPR)?

The current ratio of HYPERFINE (HYPR) is 6.15, indicating the company's ability to pay short-term obligations.

What is the gross profit of HYPERFINE (HYPR)?

The gross profit of HYPERFINE (HYPR) is $5,891,000 on a trailing twelve months (TTM) basis.

What is the operating income of HYPERFINE (HYPR)?

The operating income of HYPERFINE (HYPR) is -$43,224,000.

What is Hyperfine Inc and what does it do?

Hyperfine Inc is a medical device company that develops and markets the Swoop portable MR imaging system. It provides high-quality brain images at the patient’s bedside, leveraging ultra-low-field MRI technology to enhance diagnostic access.

How does the Swoop system differ from conventional MRI machines?

The Swoop system is designed for portability and cost-effectiveness, allowing it to be used directly at the patient’s bedside. It operates on a lower magnetic field strength and offers rapid image availability compared to traditional, fixed MRI units.

What revenue streams support Hyperfine Inc’s business model?

Hyperfine Inc generates revenue through direct device sales and recurring service subscriptions that include maintenance, software updates, and bundled service offerings for its portable imaging systems.

In which clinical settings is the Swoop system particularly useful?

The Swoop system is beneficial in environments such as neurointensive care units, emergency departments, and pediatrics, where rapid bedside imaging can facilitate prompt diagnostic decision-making.

How does Hyperfine enhance clinical workflow with its technology?

By providing a portable imaging solution that requires minimal training and offers swift image results, the Swoop system streamlines the imaging process. This allows clinicians to integrate advanced diagnostic capabilities seamlessly into their routine patient care.

What makes Hyperfine’s approach to MRI technology innovative?

Hyperfine’s innovation lies in its ability to deliver high-quality imaging without the infrastructure demands of traditional MRI systems. Its use of portable, ultra-low-field technology redefines accessibility and provides a user-friendly, cost-effective alternative for diagnostic imaging.

How does the Swoop system support patient-centered care?

The system’s mobility allows it to be used wherever patients are located, eliminating the need to transport patients to fixed imaging centers. This accessibility promotes faster diagnosis and treatment, especially in critical care settings.

How is the training process for the Swoop system structured?

The Swoop system is designed for operational simplicity, with clinicians becoming proficient in its operation and navigation within a short duration. This ease of training supports its integration into various clinical environments smoothly.